Autologous Menstrual Blood Stem Cells（Avicenna Research Institute）

N/A

Report date: 2023/01/31 20:00:21

Base Information

Drug NameAutologous Menstrual Blood Stem Cells（Avicenna Research Institute）

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Menstrual Blood-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsInfertility, Female

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesAvicenna Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesAvicenna Research Institute

Inactive CompaniesN/A

Active IndicationsInfertility, Female

Inactive IndicationsN/A

Other Information

ATC CodeN/A